AI research
Study treatment outcomes.
Develop and evaluate investigational AI models to study disease progression and treatment outcomes.
Research approachAI & clinical research
We develop investigational AI models, identify potential clinical trial opportunities, and help partners organize clinical research. Each capability addresses a different part of the work.
Research tools and practical support for researchers, clinical teams, sponsors and study sites.
AI research
Develop and evaluate investigational AI models to study disease progression and treatment outcomes.
Research approachTrial matching
Navigator analyzes patient records against clinical trial criteria, with professional review of potential matches.
Explore NavigatorStudy support
Help partners organize studies, define relevant patient populations and coordinate clinical collaborators.
Study supportAI research
Our cancer research models explore disease progression and treatment outcomes. Different questions require different models and careful evaluation.
Disease progression
Examine how disease may progress and estimate outcomes within a defined patient population.
Treatment comparisons
Investigate estimated differences between treatment approaches, accounting for the limits of observational data.
Specify the population, outcome and comparison.
Assess performance, uncertainty and differences between populations.
Identify what the evidence supports and what needs further study.
Investigational research tools, not for individual treatment selection. These models have not been shown to improve patient outcomes.
Supporting partner programs
Alongside our own research, Bowhead supports partner-led clinical programs. Our work includes helping organize trials, identify patient populations and work with collaborators.
Our clinical trial network supports studies across academic and community research sites, with expertise in vaccine and other clinical development programs.
Explore the trial networkStart with your research question, study or partnership opportunity.